Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin. - Archive ouverte HAL Access content directly
Journal Articles Comptes Rendus Biologies Year : 2006

Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin.

(1) , , (1, 2)
1
2

Abstract

Doxorubicin and other anthracyclines are among the most potent chemotherapeutic drugs for the treatment of acute leukaemia, lymphomas and different types of solid tumours such as breast, liver and lung cancers. Their clinical use is, however, limited by the risk of severe cardiotoxicity, which can lead to irreversible congestive heart failure. There is increasing evidence that essential components of myocardial energy metabolism are among the highly sensitive and early targets of doxorubicin-induced damage. Here we review doxorubicin-induced detrimental changes in cardiac energetics, with an emphasis on the emerging importance of defects in energy-transferring and -signalling systems, like creatine kinase and AMP-activated protein kinase.

Dates and versions

inserm-00390889 , version 1 (03-06-2009)

Identifiers

Cite

Malgorzata Tokarska-Schlattner, Théo Wallimann, Uwe Schlattner. Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin.. Comptes Rendus Biologies, 2006, 329 (9), pp.657-68. ⟨10.1016/j.crvi.2005.08.007⟩. ⟨inserm-00390889⟩

Collections

INSERM UGA LBFA
32 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More